Navigation Links
New Data Published in Immunobiology Describe Mode of Action of BiTE Antibody MT110
Date:1/28/2009

er of its product pipeline in preclinical development. The Company's lead program is a BiTE antibody known as blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). The Company owns all rights to MT110, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a conventional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet has licensed a fourth clinical stage antibody, MT293, to TRACON Pharmaceuticals, Inc. MT293 is being developed in a phase 1 clinical trial for the treatment of patients with cancer. The Company's preclinical programs include MT203, which is being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Micromet has granted an exclusive option to Bayer Schering Pharma AG to license a BiTE antibody against an undisclosed solid tumor target. Additional BiTE antibodies, targeting CEA, CD33, Her2, EGFR and MCSP, respectively, are in different stages of preclinical development.

Forward-Looking Statements

This release
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Published reports inaccurate concerning alcohol consumption during pregnancy
2. Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID
3. New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events
4. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
5. New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper
6. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
7. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
8. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
9. Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration
10. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
11. International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... It’s very easy to become overwhelmed with the ... to the wayside until Christmas and the New Year are ... and that burning desire to just escape it all and ... to Telluride with a no-fuss, affordable package. Montrose Days Inn ... resort, and ensure that all accommodations are met. Plus, everyone ...
(Date:12/19/2014)... Silver Dollar City is picking ... for the first time ever, Silver Dollar City has a ... Records 2015, listing the park’s wood coaster Outlaw Run as ... awards announced this week, Silver Dollar City is named in ... US,” USA Today’s 10Best awards for “Best Public Lights Display,” ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, ... respected cosmetic brand Juvéderm. Voluma XC treats volume loss ... Medspa at Hendrick is pleased to be able to ... to its clients. , Voluma is the first and ... treat the mid-face and cheek area. This non-invasive treatment ...
(Date:12/19/2014)... News) -- Potentially illness-causing E. coli bacteria were found ... according to a new study. Researchers checked cilantro, ... farmers markets in Los Angeles and Orange counties in ... 150 samples tested, 24 percent were positive for E. ... the researchers. Both types of bacteria can cause ...
(Date:12/19/2014)... NC (PRWEB) December 19, 2014 Surviving Mesothelioma ... and EPA information indicates that these pipes can leach asbestos ... go to the full story on the Surviving Mesothelioma ... the erosion of natural asbestos deposits, decaying water mains made ... drinking water. , To protect consumers from mesothelioma ...
Breaking Medicine News(10 mins):Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2
... March 25 MarketResearch.com, the leading,distributor of ... a,business partnership with Steinkrug Publications which allows ... market analyses,through the MarketResearch.com website., The ... access to complete product descriptions and tables ...
... by Novel Emerging Therapies, Including Drugs from Arena ... Resources, WALTHAM, Mass., March 25 Decision Resources, ... pharmaceutical and,healthcare issues, finds that the obesity drug market ... Kingdom and Japan will experience,more than five-fold growth, rising ...
... Famed ,Father of Aerobics, Dr. Kenneth Cooper Credited with ... to Children, DALLAS, March 25 Aerobics. For ... forms of exercise from the jogging,craze to dancing in ... one man, aerobics was a journey to define physical ...
... Calif., March 25 Ingenuity Systems, the,leading ... researchers,today announced it has achieved key milestones ... (CRADA) with the Food and Drug,Administration. Significant ... the curation of new biomarker and toxicology ...
... LEHIGH VALLEY, Pa., March 25 Spring has ... preparing for warmer days and,wearing lighter, figure revealing ... Tammy Lakatos-Shames and Lyssie,Lakatos, RD, LD, CDN, CPT, ... in overall wellness., Whether trying to lose ...
... fewer symptoms of anxiety or depression, while children with ... difficulties forming relationships and being accepted by friends. However, ... depression lead to the social problems, or vice versa. ... to contribute to anxiety and depression than the reverse. ...
Cached Medicine News:Health News:MarketResearch.com Announces Distribution of CarbonFree Research 2Health News:Drug Treatment Market For Obesity Will Increase More Than Five-Fold, Reaching $2.7 Billion in 2016 2Health News:Aerobics Celebrates 40th Anniversary 2Health News:Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review 2Health News:Nutrition Made Simple: Organizing Wellness for Warmer Days With DayTimers 2Health News:Youth's social problems contribute to anxiety and depression 2
(Date:12/19/2014)... 19, 2014  In the Friday, December 19 edition of ... to Healthcare Information Technology (HIT) features Konica Minolta, the company announced ... partnership with several leading healthcare organizations. In addition ... metropolitan markets, such as New York , ... Baltimore , Minneapolis and ...
(Date:12/19/2014)... -- TODAY, AEGATE, the leader in medicine ... appointment of Peter Fox as Chief Technology ... Partner Officer. Peter has served as Development ... by Oracle in 2011. Prior to Datanomic, ... and subsequently Convergys, a world renowned billing system ...
(Date:12/19/2014)...  Newport Corporation (NASDAQ: NEWP ) ... the company,s Board of Directors.  Dr. Kadia is ... of Evans Analytical Group, a leading global provider ... to companies in a wide range of industries.   ... Group, Dr. Kadia spent nine years with Life ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: